CMS offering tools, support, results

A report from the Centers for Medicare & Medicaid Services indicates that more providers are taking part in the Physician Quality Reporting System (PQRS) and electronic prescribing (eRx) is rising.

Participation from 2011 to 2012 increased by 36 percent for the PQRS program, and by 22 report for the eRx Program. The report also found that PQRS participation is highest among eligible professionals who see the most Medicare patients.

In total, 2012 PQRS incentive payments totaled about $168 million and eRx incentive payments totaled about $335 million, CMS reported.

Meanwhile, a new HL7 Immunization User Group will offer members access to industry experts and peers for help with resolving challenges related to implementing HL7 immunization standards.

HL7 International and the American Immunization Registry Association jointly announced the new user group. Members can seek assistance at monthly meetings to avoid problems that might otherwise impede progress on immunization-related healthcare interoperability projects. 

And, updated specifications for the eligible hospital 2014 clinical quality measures finalized in Meaningful Use Stage 2 of the EHR incentive program are now available on the CMS website. 

The agency also launched a new tool called Bonnie that supports measure developers in an e-specification of clinical quality measures. It will allow developers to independently load quality measure definitions from the Measure Authoring Tool, convert measure definitions into a format allowing execution of the measure logic and rapidly craft synthetic test patients.

Hopefully, these developments are proving CMS' pledge to simplify expectations and requirements to be the case for providers.

Beth Walsh

Clinical Innovation + Technology editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.